These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17284641)

  • 1. Commentary: Guideline for male testosterone therapy: a regulatory perspective.
    Shames D; Gassman A; Handelsman H
    J Clin Endocrinol Metab; 2007 Feb; 92(2):414-5. PubMed ID: 17284641
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: Guideline for male testosterone therapy: a clinician's perspective.
    Morgentaler A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):416-7. PubMed ID: 17284642
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary: Guideline for male testosterone therapy: a European perspective.
    Wu FC
    J Clin Endocrinol Metab; 2007 Feb; 92(2):418-9. PubMed ID: 17284643
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology.
    Isidori AM; Balercia G; Calogero AE; Corona G; Ferlin A; Francavilla S; Santi D; Maggi M
    J Endocrinol Invest; 2015 Jan; 38(1):103-12. PubMed ID: 25384570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone therapy: where do the latest guidelines agree and differ?
    Pelzman DL; Hwang K
    Curr Opin Endocrinol Diabetes Obes; 2020 Dec; 27(6):397-403. PubMed ID: 33044244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of androgens.
    Snyder PJ
    Annu Rev Med; 1984; 35():207-17. PubMed ID: 6372655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of male hypogonadism and testosterone therapy: European Association of Urology position statement on the role of the urologist.
    Alcántara Montero A
    Actas Urol Esp (Engl Ed); 2018 Apr; 42(3):212-213. PubMed ID: 28988029
    [No Abstract]   [Full Text] [Related]  

  • 9. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
    Brunton SA; Sadovsky R
    J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism: A Systematic Analysis.
    Seftel AD
    J Urol; 2016 Feb; 195(2):441. PubMed ID: 26853008
    [No Abstract]   [Full Text] [Related]  

  • 11. Testosterone replacement therapy: current trends and future directions.
    Nieschlag E; Behre HM; Bouchard P; Corrales JJ; Jones TH; Stalla GK; Webb SM; Wu FC
    Hum Reprod Update; 2004; 10(5):409-19. PubMed ID: 15297434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone for 'late-onset hypogonadism' in men?
    Drug Ther Bull; 2010 Jun; 48(6):69-72. PubMed ID: 20530029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and management of male androgen disorders: an update.
    Chan I; Fui MN; Zajac JD; Grossmann M
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypogonadism and cardiovascular diseases in men].
    Ter Arkh; 2011; 83(10):61-7. PubMed ID: 22185029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Science and Society: Testosterone replacement therapy and the knowledge gap.
    Yi YA; Dupree JM
    Nat Rev Urol; 2017 Jun; 14(6):332-333. PubMed ID: 28485412
    [No Abstract]   [Full Text] [Related]  

  • 17. Testosterone replacement therapy: take an informed, individualized approach.
    Coplan B; Spiegel J; Bleaman I; Roch J
    JAAPA; 2011 Jan; 24(1):42-7. PubMed ID: 21261147
    [No Abstract]   [Full Text] [Related]  

  • 18. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
    Meza J; Weaver K; Martin S
    Am Fam Physician; 2013 Oct; 88(8):Online. PubMed ID: 24364582
    [No Abstract]   [Full Text] [Related]  

  • 19. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical practice guidelines for screening and monitoring male patients receiving testosterone supplementation therapy.
    Morales A; Bain J; Ruijs A; Chapdelaine A; Tremblay RR
    Int J Impot Res; 1996 Jun; 8(2):95-7. PubMed ID: 8858399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.